Post-Traumatic Stress Disorder Treatment Market Growth, Size, Trends, Demand and Future Scope
Post-Traumatic Stress Disorder Treatment Market Size – By Drug Type, By Age Group, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
| Published: Dec-2022 | Report ID: HLCA2234 | Pages: 1 - 232 | Formats*: |
| Category : Healthcare | |||
Post-Traumatic Stress Disorder Treatment Market Introduction and Overview
According to SPER Market Research, the Global Post-Traumatic Stress Disorder Treatment Market is estimated to reach USD 27.77 billion by 2032 with a CAGR of 5.14%.
The report includes an in-depth analysis of the Global Post-Traumatic Stress Disorder Treatment market, including market size and trends, product mix, distribution channels, and supplier analysis. Post-traumatic stress disorder (PTSD) can occur in persons who have encountered a significant shock, such as a natural disaster, a life-threatening event, a vehicle accident, sexual abuse, and so on. PTSD symptoms can appear three months or even a year later. Most PTSD patients have symptoms such as intrusive memories, avoidance, negative thinking changes, and altered emotional and physical responses. For example, the sudden death of a loved one may trigger PTSD in some people.
- At Biomed Israel, Madrigal Mental Care demonstrated its nanotechnology for the treatment and prevention of post-traumatic stress disorder.
- Mydecine Innovations Group Inc. partnered with Combat Stress and King's College London to treat post-traumatic stress disorder (PTSD) in veterans by using psilocybin in psychoactively aided psychotherapy.
Market Opportunities and Challenges
The Post-Traumatic Stress Disorder Treatment market has a variety of opportunities and challenges. On the opportunity side, the key factors driving the growth of the post-traumatic stress disorder treatment market are an increase in the prevalence of post-traumatic stress disorder globally, an increase in the number of clinical trials related to the treatment of post-traumatic stress disorder, and an increase in research and development efforts aimed at introducing novel therapies and medications. Furthermore, the market is expected to grow due to various factors, including the growing prevalence of post-traumatic stress disorder (PTSD) globally, an increase in clinical trials for PTSD treatment, and an increase in research and development of new therapies and medications for PTSD.
The high cost of care places significant restrictions on the market for post-traumatic stress disorder treatment. Post-traumatic stress disorder (PTSD) is becoming more commonplace worldwide, more clinical research is being done to treat PTSD, and more new PTSD therapies and drugs are being developed; all of these factors have led to the market's growth. Furthermore, the other obstacles impeding the growth of the post- Traumatic Stress Disorder treatment market, however, are the adverse effects of treatment for post-traumatic stress disorder and its high cost.
-006195725102023.jpg)
Market Competitive Landscape
The market for treatments for post-traumatic stress disorder is crowded, with many domestic and foreign competitors. To improve their market presence, the major players are implementing a variety of growth tactics, including alliances, partnerships, joint ventures, new product launches, geographic expansions, mergers, and acquisitions. Lupin Limited, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc, and Merck KGaA are a few of the major companies in the industry.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Drug Type, By Age Group, By Distribution Channel, By End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | Allergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd. |
COVID-19 Impact on Global Post-Traumatic Stress Disorder Treatment Market
The market for posttraumatic stress disorder (PTSD) treatment has been severely affected by the COVID-19 pandemic, an unprecedented health hazard. Numerous research have demonstrated that COVID-19 raises the risk of PTSD, and as a result, there is a growing need for PTSD treatment. For example, a review article published in August 2021 titled "COVID-19 and Posttraumatic Stress Disorder: The Perfect 'Storm' for Mental Health (Review)" showed that COVID-19 has a major effect on mental health and increases the risk of developing trauma-related disorders, including PTSD, in those who are most susceptible, such as children, adolescents, and adult COVID-19 survivors.
Key Target Audience
- Hospitals
- Mental Health Centre
- Outpatient Clinics
Our in-depth analysis of the Post-Traumatic Stress Disorder Treatment Market includes the following segments:
| By Drug Type: |
|
| By Age Group: |
|
| By Distribution Channel: |
|
| By End User: |
|
| By Region: |
|
Key Topics Covered in the Report
- Global Post-Traumatic Stress Disorder Treatment Market Size (FY’2022-FY’2032)
- Overview of Global Post-Traumatic Stress Disorder Treatment Market
- Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Drug Type (Anti-anxiety, Antidepressants, Antipsychotics, Beta-blockers, Monoamine Oxidase, Others)
- Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Age Group (Paediatrics, Geriatrics, Adults)
- Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
- Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By End User (Mental Health Centre, Hospitals, Outpatient Clinics, Others) Statistical Snap of Global Post-Traumatic Stress Disorder Treatment Market
- Expansion Analysis of Global Post-Traumatic Stress Disorder Treatment Market
- Problems and Obstacles in Global Post-Traumatic Stress Disorder Treatment Market
- Competitive Landscape in the Global Post-Traumatic Stress Disorder Treatment Market
- Impact of COVID-19 and Demonetization on Global Post-Traumatic Stress Disorder Treatment Market
- Details on Current Investment in Global Post-Traumatic Stress Disorder Treatment Market
- Competitive Analysis of Global Post-Traumatic Stress Disorder Treatment Market
- Prominent Players in the Global Post-Traumatic Stress Disorder Treatment Market
- SWOT Analysis of Global Post-Traumatic Stress Disorder Treatment Market
- Global Post-Traumatic Stress Disorder Treatment Market Future Outlook and Projections (FY’2022-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Post-Traumatic Stress Disorder Treatment Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Post-Traumatic Stress Disorder Treatment Manufacturing Base Distribution, Sales Area, Product Type6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Post-Traumatic Stress Disorder Treatment Market
7. Global Post-Traumatic Stress Disorder Treatment Market, By DrugType, 2019-2032 (USD Million)
7.1 Anti-anxiety7.2 Antidepressants7.3 Antipsychotics7.4 Beta-blockers7.5 Monoamine Oxidase7.6 Others
8. Global Post-Traumatic Stress Disorder Treatment Market, By Age Group, 2019-2032 (USD Million)
8.1 Paediatrics8.2 Geriatrics8.3 Adults
9. Global Post-Traumatic Stress Disorder Treatment Market, By Distribution Channel, 2019-2032 (USD Million)
9.1 Hospital Pharmacies9.2 Retail Pharmacies9.3 Online Pharmacies
10. Global Post-Traumatic Stress Disorder Treatment Market, By End User, 2019-2032 (USD Million)
10.1 Mental Health Center10.2 Hospitals10.3 Outpatient Clinics10.4 Others
11. Global Post-Traumatic Stress Disorder Treatment Market, By Region, 2019-2032 (USD Million)
11.1 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2019-2025)11.2 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2026-2032)11.3 Asia-Pacific
11.3.1 Australia11.3.2 China11.3.3 India11.3.4 Japan11.3.5 South Korea11.3.6 Rest of Asia-Pacific
11.4 Europe
11.4.1 France11.4.2 Germany11.4.3 Italy11.4.4 Spain11.4.5 United Kingdom11.4.6 Rest of Europe
11.5 Middle East & Africa
11.5.1 Kingdom of Saudi Arabia11.5.2 United Arab Emirates11.5.3 Rest of Middle East & Africa
11.6 North America
11.6.1 Canada11.6.2 Mexico11.6.3 United States
11.7 South America
11.7.1 Argentina11.7.2 Brazil11.7.3 Rest of South America
12. Company Profiles
12.1 Allergan PLC
12.1.1 Company details12.1.2 Financial outlook12.1.3 Product summary12.1.4 Recent developments
12.2 Amneal Pharmaceuticals LLC
12.2.1 Company details12.2.2 Financial outlook12.2.3 Product summary12.2.4 Recent developments
12.3 Apotex Inc.
12.3.1 Company details12.3.2 Financial outlook12.3.3 Product summary12.3.4 Recent developments
12.4 AstraZeneca
12.4.1 Company details12.4.2 Financial outlook12.4.3 Product summary12.4.4 Recent developments
12.5 Aurobindo Pharma
12.5.1 Company details12.5.2 Financial outlook12.5.3 Product summary12.5.4 Recent developments
12.6 Bausch Health Companies Inc.
12.6.1 Company details12.6.2 Financial outlook12.6.3 Product summary12.6.4 Recent developments
12.7 Bristol-Myers Squibb
12.7.1 Company details12.7.2 Financial outlook12.7.3 Product summary12.7.4 Recent developments
12.8 Eli Lilly and Company
12.8.1 Company details12.8.2 Financial outlook12.8.3 Product summary12.8.4 Recent developments
12.9 GlaxoSmithKline PLC
12.9.1 Company details12.9.2 Financial outlook12.9.3 Product summary12.9.4 Recent developments
12.10 Johnson and Johnson
12.10.1 Company details12.10.2 Financial outlook12.10.3 Product summary12.10.4 Recent developments
12.11 Mylan Pharmaceuticals
12.11.1 Company details12.11.2 Financial outlook12.11.3 Product summary12.11.4 Recent developments
12.12 Pfizer Inc.
12.12.1 Company details12.12.2 Financial outlook12.12.3 Product summary12.12.4 Recent developments
12.13 Sun Pharmaceuticals Pvt Ltd
12.13.1 Company details12.13.2 Financial outlook12.13.3 Product summary12.13.4 Recent developments
12.14 Teva Pharmaceuticals Industries Ltd.
12.14.1 Company details12.14.2 Financial outlook12.14.3 Product summary12.14.4 Recent developments
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The Post-Traumatic Stress Disorder Treatment Market is projected to reach USD 27.77 billion by 2032, growing at a CAGR of 5.14% during the forecast period.
The Post-Traumatic Stress Disorder Treatment Market grew in market size from 2021. The Market is expected to reach USD 27.77 billion by 2032, at a CAGR of 5.14% during the forecast period.
The Post-Traumatic Stress Disorder Treatment Market CAGR of 5.14% during the forecast period.
You can get the sample pages by clicking the link -Click Here
The Post-Traumatic Stress Disorder Treatment Market size is USD 27.77 billion from 2022 to 2032.
The Post-Traumatic Stress Disorder Treatment Market segment is Covered By Drug Type, By Age Group, By Distribution Channel, By End User.
The North America region is anticipated to have the highest market share in the Post-Traumatic Stress Disorder Treatment Market.
The key players in the market include Companies Covered Allergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd.
The market for treating post-traumatic stress disorder is severely constrained by the high cost of care.The prevalence of post-traumatic stress disorder (PTSD) is rising globally, there are more clinical studies being conducted to treat PTSD, and there has been an increase in the development of new PTSD treatments and medications, all of which have contributed to the market's expansion.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
